Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn R Cho

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|April 7, 2022
Perspectives on training quantitative systems pharmacologistsTongli Zhang, Carolyn R Cho, Peter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|November 18, 2021
From complex data to biological insight: 'DEKER' feature selection and network inferenceSean M S Hayes, Jeffrey R Sachs, Carolyn R Cho
Journal of Pharmacokinetics and Pharmacodynamics|May 5, 2025
Leveraging large language models to compare perspectives on integrating QSP and AI/MLIoannis P Androulakis, Limei Cheng, Carolyn R Cho, et al.
Novartis Foundation Symposium|January 24, 2003
Using in silico biology to facilitate drug developmentJeremy M Levin, R Christian Penland, Andrew T Stamps, et al.
Clinical Pharmacology and Therapeutics|June 15, 2018
PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product LabelingYing-Hong Wang, Dapeng Chen, Georgy Hartmann, et al.
Current Opinion in Chemical Biology|July 11, 2006
The application of systems biology to drug discoveryCarolyn R Cho, Mark Labow, Mischa Reinhardt, et al.
Journal of Theoretical Biology|July 6, 2004
Modeling the interactions between osteoblast and osteoclast activities in bone remodelingVincent Lemaire, Frank L Tobin, Larry D Greller, et al.
Clinical Pharmacology and Therapeutics|January 1, 2020
A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision MakingSandra A G Visser, Bhargava Kandala, Craig Fancourt, et al.
Journal of Clinical Pharmacology|April 26, 2019
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical StudiesJulie Kobie, Zifang Guo, Carolyn R Cho, et al.
Clinical and Translational Science|April 22, 2023
Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological-based pharmacokinetic modelingKarsten Menzel, Yuhsin Kuo, Dapeng Chen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|April 7, 2022
Perspectives on training quantitative systems pharmacologistsTongli Zhang, Carolyn R Cho, Peter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|November 18, 2021
From complex data to biological insight: 'DEKER' feature selection and network inferenceSean M S Hayes, Jeffrey R Sachs, Carolyn R Cho
Journal of Pharmacokinetics and Pharmacodynamics|May 5, 2025
Leveraging large language models to compare perspectives on integrating QSP and AI/MLIoannis P Androulakis, Limei Cheng, Carolyn R Cho, et al.
Novartis Foundation Symposium|January 24, 2003
Using in silico biology to facilitate drug developmentJeremy M Levin, R Christian Penland, Andrew T Stamps, et al.
Clinical Pharmacology and Therapeutics|June 15, 2018
PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product LabelingYing-Hong Wang, Dapeng Chen, Georgy Hartmann, et al.
Current Opinion in Chemical Biology|July 11, 2006
The application of systems biology to drug discoveryCarolyn R Cho, Mark Labow, Mischa Reinhardt, et al.
Journal of Theoretical Biology|July 6, 2004
Modeling the interactions between osteoblast and osteoclast activities in bone remodelingVincent Lemaire, Frank L Tobin, Larry D Greller, et al.
Clinical Pharmacology and Therapeutics|January 1, 2020
A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision MakingSandra A G Visser, Bhargava Kandala, Craig Fancourt, et al.
Journal of Clinical Pharmacology|April 26, 2019
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical StudiesJulie Kobie, Zifang Guo, Carolyn R Cho, et al.
Clinical and Translational Science|April 22, 2023
Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological-based pharmacokinetic modelingKarsten Menzel, Yuhsin Kuo, Dapeng Chen, et al.
Pageof 2